| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.31T | 2.13T | 1.85T | 1.73T | 1.50T |
| Gross Profit | 454.92B | 431.54B | 312.24B | 333.82B | 256.58B |
| EBITDA | 270.62B | 214.33B | 117.88B | 157.46B | 106.66B |
| Net Income | 108.16B | 88.00B | 25.38B | 53.03B | 21.80B |
Balance Sheet | |||||
| Total Assets | 3.32T | 3.02T | 2.68T | 2.46T | 2.17T |
| Cash, Cash Equivalents and Short-Term Investments | 115.41B | 132.78B | 84.15B | 138.42B | 108.51B |
| Total Debt | 861.19B | 889.51B | 845.23B | 785.26B | 666.84B |
| Total Liabilities | 2.38T | 2.29T | 2.03T | 1.86T | 1.65T |
| Stockholders Equity | 878.12B | 702.91B | 634.09B | 576.20B | 505.48B |
Cash Flow | |||||
| Free Cash Flow | 44.09B | 50.26B | -48.40B | -35.33B | 97.95B |
| Operating Cash Flow | 140.07B | 148.94B | 31.66B | 23.62B | 156.89B |
| Investing Cash Flow | -128.05B | -111.20B | -89.81B | -77.46B | -58.40B |
| Financing Cash Flow | -33.23B | 9.61B | 12.91B | 85.31B | -108.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥1.24T | 21.24 | 12.13% | 1.21% | 7.54% | 13.65% | |
69 Neutral | ¥2.52T | 31.76 | 16.00% | 1.38% | 12.02% | 9.75% | |
69 Neutral | ¥3.01T | 17.22 | 10.09% | 0.97% | 5.35% | 26.51% | |
66 Neutral | ¥2.38T | 21.90 | 14.59% | 1.40% | 8.54% | 23.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥617.42B | 19.58 | 4.83% | 2.95% | 2.18% | 5504.89% | |
57 Neutral | ¥2.62T | 16.00 | 23.30% | 0.71% | 1.02% | 42.74% |